Navigation Links
Wyeth Donates $100,000 to ASCO Cancer Foundation(R) to Support Cancer Prevention and Care
Date:5/30/2009

COLLEGEVILLE, Pa., May 30 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), has donated $100,000 to The American Society of Clinical Oncology (ASCO) Cancer Foundation to help support its efforts to advance cancer research, provide patients with important health information and conduct physician education programs. The donation was presented today during the 45th Annual Meeting of the American Society of Clinical Oncology in Orlando, Fla.

"Wyeth is proud to support The ASCO Cancer Foundation and its ongoing mission to improving the lives of people with cancer. With this contribution, we hope to help the Foundation in its important educational and research efforts to reach more patients and their families, and to provide additional resources to the researchers seeking new treatments to help better manage cancer," said Mikael Dolsten, M.D., Ph.D., President, Research and Development, Wyeth Pharmaceuticals.

"We are honored to receive this generous donation from Wyeth," said Dr. Joseph Bailes, Chair, The ASCO Cancer Foundation. "As we celebrate our 10th Anniversary this year, we are especially grateful to all the organizations that have helped us achieve this important milestone. This donation will help us continue to make a world of difference in cancer care."

The American Cancer Society projected that more than 1.4 million people in the United States would be diagnosed with cancer in 2008. While the overall incidence of cancer has declined in the past several years, these statistics vary greatly by type of cancer and stage at diagnosis.

Wyeth Pharmaceuticals researches, develops and markets therapies for the treatment of cancer.

The ASCO Cancer Foundation supports educational programs of the highest quality in cancer care and prevention; facilitat
'/>"/>

SOURCE Wyeth Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. U.S. and 16 States Join Suits Against Pharmaceutical Giant, Wyeth
2. Wyeth Reports Earnings Results for the 2009 First Quarter
3. Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
4. Wyeths CONBRIZA Approved in the European Union for Treatment of Postmenopausal Osteoporosis in Women at Increased Risk of Fracture
5. Wyeth Reduces Risk with Dyadem Software
6. Wyeth Submits Marketing Application to FDA for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Toddlers
7. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
8. DRI - the Voice of the Defense Bar Responds to Supreme Court Ruling in Wyeth v. Levine
9. Wyeth Comments on U.S. Supreme Court Ruling in Levine Preemption Case
10. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
11. Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)..., N.J. and ANDOVER, Mass., Dec. 3 ...gence® company, and Visage Imaging® Inc....SX: PME) announced today that they have entered in...anced oncology solutions for the clinical and prec...les Definiens to utilize the Visage® CS enter...
(Date:12/3/2009)...PRNewswire-USNewswire/ -- To honor 30 years of sup... has created a named award for a long-serving emp...pe Gaye presented the inaugural Pauline Muhuhu Lea...eremony at the non-profit,s North Carolina headqua...raHealth seeks to recognize health workers who ded...
(Date:12/3/2009)...dical, a leading global healthcare company special...ced that international medical quality authority, ...y Advisory Board (MQAB). , ...Satori World Medical, a leading global healthcare ...l space, announced that international medical qual...
(Date:12/3/2009)...ed to smoke are at risk of lung cancer , ...ctal cancer to the list of malignancies caused by ...etween the two. , And other studies are providi... quit: Two papers published in the December issue ...themed issue on tobacco, strengthen the case for t...
(Date:12/3/2009)...k Educates Americans About This Growing Epidemi... DETROIT, Dec. 3 In the...s every 21 seconds. On December 5, 2009, the Detro...Diabetes: A Deeper Look, to help answer questions...es treatment and the role insulin plays in the bod...
Breaking Medicine News(10 mins):Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3Health News:Inaugural 'Health Worker Leadership Award' Honors Kenyan Midwife, IntraHealth Senior Leader 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 2Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 3Health News:Former Chief Medical Officer of Joint Commission International Joins Satori World Medical's Medical Quality Advisory Board 4Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 2Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 3Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 4Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 2Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 4
...ticles, engineered materials about a billionth of ...er, according to research// presented at the 2007 ...cer Research. Nanoparticles are small enough t...ersity of Massachusetts say. Such nanoparticles ar...
...A) of the US has granted approval to a French drug...//. However it says it is only an interim measure ...he U.S. Foood and Drug Administration (FDA) has ap...tis, the world's third largest drug-maker. At ...
...r diet rich in vegetables can offer protection fro... The studies presented at the annual meeting...n Los Angeles show that the fruits and vegetables ... women and found a diet high in flavonol-rich appl...
...stro-oesophageal reflux disease, British doctors w...s a relatively new phenomenon. Statistics sh...phageal reflux disease, also known as the GORD, an...latively new phenomenon and that although most med...
... of melting to a chocolate gave an intense high, f... The finding which could cause many hearts to sink...quivalent to hugging and kissing your loved one, f...bjects were sized up from their heart and head; th...
...at red wine is good for health, leading Indian doc...roved the positive side of either the red wine or ...octors assembled in the national capital to partic... "I have gone through nearly 1.6 crores (16 ...
Other Medicine News:Health News:Nanoparticles can Damage DNA, Increase Cancer Risk 2Health News:FDA Grants Approval to First Bird Flu Vaccine 2Health News:Doctors in UK Promoting Awareness of Gastro-oesophageal Reflux Disease 2Health News:Doctors in UK Promoting Awareness of Gastro-oesophageal Reflux Disease 3Health News:Red Wine Good for Nothing, Say Indian Doctors 2
(Date:12/3/2009)..., Dec. 3 VirtualScopics,...ntitative imaging for clinical trials, announced t... 4D Reconstruction and Visualization" recently rec...e President of Technology and Product Development,...apan has recognized the uniqueness of VirtualScopi...
(Date:12/3/2009)... and NEEDHAM, Massachusetts, December 3 /PRNewswir...change: ORIDN) today announced that the Bavarian R...hs for its RTW (Rettungswagen) medical vehicles. T...assess the ventilation status of a patient as well...tatus such as displaced endotracheal tubes, episod...
(Date:12/2/2009)..., Dec. 2 Reportlinker.com announc...in its catalogue: ,, Hospital Information Syst...tunities ,, http://www.reportlinker.com/p0164...-of-Market-Trends--Opportunities.html ,, Incre...he benefits of using Information Technology in the...
Breaking Medicine Technology:VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Hospital Information Systems - A Global Update of Market Trends & Opportunities 8Vaporized Propylene Glycol a Key Ingredient in Electronic Cigarettes May Prevent Pneumonia Influenza and Other Respiratory Diseases 60489 1Vaporized Propylene Glycol a Key Ingredient in Electronic Cigarettes May Prevent Pneumonia Influenza and Other Respiratory Diseases 60489 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 11 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 21 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 31 9 Million Drivers Have Fatigue Related Car Crashes or Near Misses Each Year 60486 4Cell Therapeutics Inc 28CTI 29 to Report Third Quarter Financial Results on November 5 60483 1
...rthwest,Biotherapeutics, Inc. (OTC Bulletin Board:...") today announced the most recent long-term,follo...hase I and Phase,I/II clinical trials with DCVax(R...s with Glioblastoma multiforme, the most lethal ty... 84% of patients who received,DCVax(R)-Brain in th...
...ing acquisition of Organon BioSciences, KENILWORT...SE: SGP ) today announced that the European launc...ith its introduction this week,in Sweden, and that...he,United Kingdom and Germany, with several other ...and in early 2009., "The introduction of BRIDION ...
Other Medicine Technology:Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 2Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 3Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 4Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 5Long-Term Phase I and Phase I/II Trial Data Continue to Show Striking Improvement in Survival of Brain Cancer Patients Who Receive DCVax(R)-Brain 6Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex) 2Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex) 3
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
...tory and a worldwide leader in innovative laborato...ive test menu of highly complex and unique medical...y the University of Utah, ARUP Laboratories' clien...ty teaching hospitals and children's hospitals, ma...
Medicine Products: